In vitro observations on the suitability of new rifamycins for the intermittent chemotherapy of tuberculosis
- 1 September 1987
- Vol. 68 (3) , 183-193
- https://doi.org/10.1016/0041-3879(87)90054-7
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- In vitro activity of new rifamycins aganst rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteriaTubercle, 1987
- In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosisTubercle, 1987
- Laboratory evaluation of a new long-acting 3-azinomethylrifamycin FCE 22250.The Journal of Antibiotics, 1985
- LM 427,a new spiropiperidylrifamycin: In vitro and in vivo studies.The Journal of Antibiotics, 1983
- Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative.The Journal of Antibiotics, 1981
- Biological activity of a new class of rifamycins Spiro-piperidyl-rifamycins.The Journal of Antibiotics, 1980
- Assay of rifampicin in serumJournal of Clinical Pathology, 1974
- A Selective Oleic Acid Albumin Agar Medium For Tubercle BacilliJournal of Medical Microbiology, 1972
- In vitro studies on the choice of drugs for intermittent chemotherapy of tuberculosisTubercle, 1966